Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Merck (MRK) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:16am, Monday, 27'th Oct 2025
Get a deeper insight into the potential performance of Merck (MRK) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S.
3 Healthcare Stocks That Are Screaming Deals Right Now
04:23pm, Sunday, 26'th Oct 2025
DaVita's recession-resistant business is growing internationally, but shares continue to trade at a heavily discounted valuation. Merck could be in for a major move if the pharma can soften the blow o
Merck Q3 Earnings Preview: Issues That Will Dominate The Agenda
04:24pm, Friday, 24'th Oct 2025
Merck & Co., Inc. faces a pivotal Q3 earnings report as Keytruda's patent expiration looms and pipeline diversification efforts accelerate. MRK's oncology pipeline, including Keytruda Qlex and multipl
Merck's Non-Oncology Drugs Q3 Performance: What to Expect
11:06am, Friday, 24'th Oct 2025
MRK expects new products like Capvaxive, Winrevair, and the Animal Health business to support its top-line growth in the third quarter.
Analysts Set Merck & Co., Inc. (NYSE:MRK) Price Target at $104.33
02:42am, Friday, 24'th Oct 2025
Merck and Co., Inc. (NYSE: MRK - Get Free Report) has been given a consensus rating of "Hold" by the twenty brokerages that are covering the firm, Marketbeat.com reports. One equities research analyst
5 Best Dividend Stocks in the S&P 500
12:06pm, Thursday, 23'rd Oct 2025
Income investors rarely chase the loudest headlines.
eschbach's Shiftconnector® Helps Power Merck's Visual Factory to Drive Greater Transparency, Agility, and Supply Chain Resilience
11:55am, Thursday, 23'rd Oct 2025
BOSTON , Oct. 23, 2025 /PRNewswire/ -- eschbach is pleased to share that Merck (NYSE: MRK), known as MSD outside the United States and Canada, has selected Shiftconnector to improve how it uses digit
Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 23'rd Oct 2025
Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025
06:45am, Thursday, 23'rd Oct 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced plans to present new research from the company's cardio-pulmonary portfolio and
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for
CAMBRIDGE, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncolo
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE in U.S. Adults.
JPMorgan Says Correction Will Be “Healthy” – 5 Safe High-Yield Dividend Stocks
04:12pm, Monday, 20'th Oct 2025
Jamie Dimon is one of the highest-profile bankers in the world.
My Top 3 Pharma Stocks
11:38am, Monday, 20'th Oct 2025
Obesity, type 2 diabetes, and cancer continue to grow across the globe, but pharma stocks remain off the radars of many investors. Many of them consistently beat the Street's consensus estimates and o
